OnKure (OKUR) Director Valerie Jansen Receives Award of 22,350 Shares

What Happened

• Valerie Malyvanh Jansen, a director of OnKure Therapeutics (OKUR), received a grant classified as a derivative award of 22,350 shares on 2026-08-07. The award was reported at $0.00 per share (no cash paid at grant).

Key Details

• Transaction date and type: 2026-08-07 — Grant / award (derivative option).
• Shares/price: 22,350 shares @ $0.00 (total reported value $0).
• Vesting: Footnote states 100% of the shares subject to the option vest on the earlier of June 4, 2027 or the day prior to the issuer’s next annual meeting of stockholders, provided the reporting person remains a service provider through the vesting date.
• Shares owned after transaction: Not disclosed in the provided Form 4 summary.
• Filing timeliness: Form filed 2026-08-11 for a 2026-08-07 transaction — appears to be filed after the usual 2-business-day Form 4 deadline (reported as late).

Context

• This was an option/award grant (derivative), not an open-market purchase or sale, so it signals compensation/long-term alignment rather than an immediate market bet. The award vests in the future subject to continued service; there was no immediate exercise or sale reported.